
Resonance
RHT.AXResonance Health Limited Price (RHT.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
456,064,369
(1.1027)%Description
Resonance Health Limited, a healthcare technology and services company, designs, develops, and manufactures software-as-medical devices in the Asia Pacific, North America, South America, Europe, the Middle East, and Africa. It offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-assisted device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.038-0.088
- Market Cap 19.30M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Healthcare Information Services
- ceo: Mr. Andrew Duncan Harrison BCom (Hons), MAICD
- IPO Date: January, 02, 2000
- Country: AU
- Currency: AUD
- Headquaters: Burswood, WA
- Employees: 18
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
